To TDM or not to TDM in lupus nephritis patients treated with MMF?

A Protocol for the Pharmacokinetics of Enteric Coated Mycophenolate Sodium in Lupus Nephritis (POEMSLUN): an open-label, randomised controlled trial

(2013) Dwarakanathan Ranganathan et al.   BMJ Open

Joint European League Against Rheumatism and European Renal Association–European Dialysis and Transplant Association (EULAR/ERA-EDTA) recommendations for the management of adult and paediatric lupus nephritis

(2012) George K Bertsias et al.   ANNALS OF THE RHEUMATIC DISEASES

Concentration-controlled treatment of lupus nephritis with mycophenolate mofetil

(2012) GMN Daleboudt et al.   LUPUS

American College of Rheumatology guidelines for screening, treatment, and management of lupus nephritis

(2012) Bevra H. Hahn et al.   ARTHRITIS CARE & RESEARCH

The importance of assessing medication exposure to the definition of refractory disease in systemic lupus erythematosus

(2011) Laurent Arnaud et al.   AUTOIMMUNITY REVIEWS

Development of population PK model with enterohepatic circulation for mycophenolic acid in patients with childhood-onset systemic lupus erythematosus

(2011) Catherine M. T. Sherwin et al.   BRITISH JOURNAL OF CLINICAL PHARMACOLOGY

Efficacy and safety of enteric-coated mycophenolate sodium in combination with two glucocorticoid regimens for the treatment of active lupus nephritis

(2011) M Zeher et al.   LUPUS

Steady-state mycophenolate mofetil pharmacokinetic parameters enable prediction of systemic lupus erythematosus clinical flares: an observational cohort study

(2011) Sarah Djabarouti et al.   ARTHRITIS RESEARCH & THERAPY

Therapeutic drug monitoring of mycophenolates: why make simple things complicated?

(2011) D RJ Kuypers et al.   Transplantation Reviews

Therapeutic drug monitoring of mycophenolate mofetil and enteric-coated mycophenolate sodium in patients with systemic lupus erythematosus

(2010) Sarah Djabarouti et al.   EXPERT OPINION ON PHARMACOTHERAPY

Pharmacokinetics of mycophenolic acid in severe lupus nephritis

(2010) Paungpaga Lertdumrongluk et al.   KIDNEY INTERNATIONAL

Mycophenolate, clinical pharmacokinetics, formulations, and methods for assessing drug exposure

(2010) Susan E. Tett et al.   Transplantation Reviews

Mycophenolate Mofetil versus Cyclophosphamide for Induction Treatment of Lupus Nephritis

(2009) G. B. Appel et al.   JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY

Limited Sampling Strategies Drawn Within 3 Hours Postdose Poorly Predict Mycophenolic Acid Area-Under-the-Curve After Enteric-Coated Mycophenolate Sodium

(2009) Brenda C M de Winter et al.   THERAPEUTIC DRUG MONITORING

Efficacy of enteric-coated mycophenolate sodium in patients with resistant-type lupus nephritis: a prospective study

(2008) O Traitanon et al.   LUPUS

Association between mycophenolic acid 12-h trough levels and clinical endpoints in patients with autoimmune disease on mycophenolate mofetil

(2008) I. Neumann et al.   NEPHROLOGY DIALYSIS TRANSPLANTATION